Gadolinium and nephrogenic systemic fibrosis. All quiet? Yes...! No...! Maybe...!
Balducci, A.; Tamburrini, O.
Giornale italiano di nefrologia organo ufficiale della Societa italiana di nefrologia 28(1): 4-6
2011
ISSN/ISBN: 0393-5590 PMID: 21341233 Document Number: 649691
Document emailed within 1 workday
Related Documents
Canavese, C.; Mereu, M.C.; Aime, S.; Lazzarich, E.; Fenoglio, R.; Quaglia, M.; Stratta, P. 2008: Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness Journal of Nephrology 21(3): 324-336Chen, A.Y.-Y.; Zirwas, M.J.; Heffernan, M.P. 2010: Nephrogenic systemic fibrosis: a review Journal of Drugs in Dermatology: Jdd 9(7): 829-834
Aydingöz, U.ün. 2006: The need for radiologists' awareness of nephrogenic systemic fibrosis Diagnostic and Interventional Radiology 12(4): 161-162
Graziani, G.; Montanelli, A.; Brambilla, S.; Balzarini, L. 2009: Nephrogenic systemic fibrosis an unsolved riddle Journal of Nephrology 22(2): 203-207
Robinson, M.R.; Routhouska, S.B.; Paspulati, R.M.; Korman, N.J. 2011: Alefacept therapy for nephrogenic systemic fibrosis: a case series Journal of Drugs in Dermatology: Jdd 10(8): 922-924
Stassen, P.M. 2008: Nephrogenic systemic fibrosis in stage 4 kidney disease, what is the alternative? Netherlands Journal of Medicine 66(3): 132; Author Reply 133
Michelet, P.-R.; Chopard, C.S.; Martin, P.-Y.; Vallée, J.-P. 2008: Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure Revue Medicale Suisse 4(147): 576-578; 580
Nicholas, B.A.; Vricella, G.J.; Smith, M.; Passalacqua, M.; Gulani, V.; Ponsky, L.E. 2012: Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk Canadian Journal of Urology 19(1): 6074-6080
Chomette, G.; Tranbaloc, P.; Delcourt, A.; Auriol, M. 1986: Pathological anatomy of idiopathic retroperitoneal fibrosis. the concept of multifocal systemic fibrosis Chirurgie; Memoires de l'Academie de Chirurgie 112(5): 343-348
Vieillefond, A.; Quillard, J.; Benoit, G.; Hofman-Guilaine, C.; Lebras, P. 1985: A case of nephrogenic metaplasia (or nephrogenic adenoma) of the bladder Annales de Pathologie 5(4-5): 287-290
Lichon, F.S.; Sequeira, W.; Pilloff, A.; Skosey, J.L. 1984: Retroperitoneal fibrosis associated with systemic lupus erythematosus: a case report and brief review Journal of Rheumatology 11(3): 373-374
Ferrer-Roca, O.; Segura, F.; Nogue, S.; Duro, J.C.; Soriano, E. 1979: Multifocal or systemic fibrosis with involvement of unusual areas (intracranial space) Revista Clinica Espanola 152(6): 489-494
Andy, J.J.; Ekott, J.U.; Ansa, V.O. 2010: Systemic thromboembolism in endomyocardial fibrosis (EMF): clinical observations, aetio-pathogenesis and treatment African Journal of Medicine and Medical Sciences 39(3): 207-213
Yamane, K.; Ihn, H.; Kubo, M.; Yazawa, N.; Kikuchi, K.; Soma, Y.; Tamaki, K. 2000: Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis Journal of Rheumatology 27(4): 930-934
Morelli, S.; Ferri, C. 1996: Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? Journal of Rheumatology 23(4): 789-791
Kohler, H.P.; Laeng, R.H.; Egger, C.; Streuli, R. 1995: Systemic fibrosis (generalized form of Ormond's disease). Report of a case which achieved complete remission with cyclophosphamide and corticosteroids Schweizerische Medizinische Wochenschrift 125(44): 2131-2136
Steen, V.D.; Lucas, M.; Fertig, N.; Medsger, T.A. 2007: Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody Journal of Rheumatology 34(11): 2230-2235
Ahmadi-Simab, K.; Köhler, A.; Gross, W.L. 2007: Sustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosis Clinical and Experimental Rheumatology 25(5): 760-762
Holbrook, B. 1976: The quiet group Nursing Mirror and Midwives Journal 142(17): 69-70
Oswin, M. 1992: The quiet menace Nursing Times 88(34): 40-41